题名 | Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH) | 杂志 | Journal of Clinical Oncology | 链接 | http://ascopubs.org/doi/abs/10.1200/JCO.2016.71.9476 |
本帖最后由 pendave 于 2017-6-15 19:47 编辑
http://ascopubs.org/doi/abs/10.1200/JCO.2016.71.9476 |